Publication: In Vivo Photoactivation Without “Light”: Use of Cherenkov Radiation to Overcome the Penetration Limit of Light
Date
2011
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Ran, Chongzhao, Zhaoda Zhang, Jacob Hooker, and Anna Moore. 2011. “In Vivo Photoactivation Without ‘Light’: Use of Cherenkov Radiation to Overcome the Penetration Limit of Light.” Molecular Imaging and Biology 14 (2) (May 3): 156–162. doi:10.1007/s11307-011-0489-z.
Research Data
Abstract
Purpose: The poor tissue penetration of visible light has been a major barrier for optical imaging, photoactivatable conversions, and photodynamic therapy for in vivo targets with depths beyond 10 mm. In this report, as a proof-of-concept, we demonstrated that a positron emission tomography (PET) radiotracer, 2-deoxy-2-[18F]fluoro-d-glucose (18FDG), could be used as an alternative light source for photoactivation. Procedures: We utilized 18FDG, which is a metabolic activity-based PET probe, as a source of light to photoactivate caged luciferin in a breast cancer animal model expressing luciferase. Results: Bioluminescence produced from luciferin allowed for the real-time monitoring of Cherenkov radiation-promoted uncaging of the substrate. Conclusion: The proposed method may provide a very important option for in vivo photoactivation, in particular for activation of photosensitizers for photodynamic therapy and eventually for combining radioisotope therapy and photodynamic therapy.
Description
Other Available Sources
Keywords
Terms of Use
Metadata Only